Baculovirus-transduced, VEGF-expressing adipose-derived stem cell sheet for the treatment of myocardium infarction

Biomaterials

Volumn 35, Issue 1, 2014, Pages 174-184

  Yeh, Tsung Szu ^a,b   Dean Fang, Yu Hua ^c,d   Lu, Chia Hsin ^a   Chiu, Shao Chieh ^c   Yeh, Chia Lin ^a   Yen, Tzu Chen ^c   Parfyonova, Yelena ^e,f   Hu, Yu Chen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^f MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Adipose derived stem cells; Baculovirus; Cell sheet; Gene therapy; Myocardial infarction; Vascular endothelial growth factor

Indexed keywords

ADIPOSE DERIVED STEM CELLS; BACULOVIRUS; CELL SHEET; MYOCARDIAL INFARCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BLOOD VESSELS; CELL ENGINEERING; CYTOLOGY; GENE THERAPY; STEM CELLS;

ENDOTHELIAL CELLS;

BACULOVIRUS VECTOR; VASCULOTROPIN 165;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACULOVIRUS; BACULOVIRUS EXPRESSION SYSTEM; CAPILLARY DENSITY; CARDIOVASCULAR MAGNETIC RESONANCE; CELL DENSITY; CELL SURVIVAL; COLLATERAL CIRCULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPICARDIUM; EPIDIDYMIS; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; HEART EJECTION FRACTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

ORYCTOLAGUS CUNICULUS;

ADIPOSE-DERIVED STEM CELLS; BACULOVIRUS; CELL SHEET; GENE THERAPY; MYOCARDIAL INFARCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ADIPOSE TISSUE; ANIMALS; BACULOVIRIDAE; MAGNETIC RESONANCE IMAGING; MALE; MYOCARDIAL INFARCTION; RABBITS; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84887023845     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.09.080     Document Type: Article

References (49)

1. Imanishi Y., Miyagawa S., Maeda N., Fukushima S., Kitagawa-Sakakida S., Daimon T., et al. Induced adipocyte cell-sheet ameliorates cardiac dysfunction in a mouse myocardial infarction model: a novel drug delivery system for heart failure. Circulation 2011, 124:S10-S17.
2. Matsuura K., Haraguchi Y., Shimizu T., Okano T. Cell sheet transplantation for heart tissue repair. JControl Release 2013, 169:336-340.
3. Sekine H., Shimizu T., Dobashi I., Matsuura K., Hagiwara N., Takahashi M., et al. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A 2011, 17:2973-2980.
4. Hamdi H., Planat-Benard V., Bel A., Puymirat E., Geha R., Pidial L., et al. Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections. Cardiovasc Res 2011, 91:483-491.
5. Haraguchi Y., Shimizu T., Yamato M., Okano T. Scaffold-free tissue engineering using cell sheet technology. RSC Adv 2012, 2:2184-2190.
6. Shimizu T., Yamato M., Isoi Y., Akutsu T., Setomaru T., Abe K., et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res 2002, 90:e40-e48.
7. Sekiya N., Tobita K., Beckman S., Okada M., Gharaibeh B., Sawa Y., et al. Muscle-derived stem cell sheets support pump function and prevent cardiac arrhythmias in a model of chronic myocardial infarction. Mol Ther 2013, 21:662-669.
8. Mazo M., Hernández S., Gavira J.J., Abizanda G., Araña M., López-Martínez T., et al. Treatment of reperfused ischemia with adipose-derived stem cells in a preclinical swine model of myocardial infarction. Cell Transplant 2012, 21:2723-2733.
9. Bai X., Yan Y., Song Y.-H., Seidensticker M., Rabinovich B., Metzele R., et al. Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction. Eur Heart J 2010, 31:489-501.
10. Valina C., Pinkernell K., Song Y.-H., Bai X., Sadat S., Campeau R.J., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 2007, 28:2667-2677.
11. Miyahara Y., Nagaya N., Kataoka M., Yanagawa B., Tanaka K., Hao H., et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006, 12:459-465.
12. Wang F., Guan J. Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy. Adv Drug Deliv Rev 2010, 62:784-797.
13. Eulalio A., Mano M., Ferro M.D., Zentilin L., Sinagra G., Zacchigna S., et al. Functional screening identifies miRNAs inducing cardiac regeneration. Nature 2012, 492:376-381.
14. Song K., Nam Y.-J., Luo X., Qi X., Tan W., Huang G.N., et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
15. Qian L., Huang Y., Spencer C.I., Foley A., Vedantham V., Liu L., et al. Invivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012, 485:593-598.
16. Airenne K.J., Hu Y.-C., Kost T.A., Smith R.H., Kotin R.M., Ono C., et al. Baculovirus: an insect-derived vector for diverse gene transfer applications. Mol Ther 2013, 21:739-749.
17. Lu C.-H., Lin K.-J., Chiu H.-Y., Chen C.-Y., Yen T.-C., Hwang S.-M., et al. Improved chondrogenesis and engineered cartilage formation from TGF-β3-expressing adipose-derived stem cells cultured in the rotating-shaft bioreactor. Tissue Eng Part A 2012, 18:2114-2124.
18. Lin C.-Y., Chang Y.-H., Lin K.-J., Yen T.-Z., Tai C.-L., Chen C.-Y., et al. The healing of critical-sized femoral segmental bone defects in rabbits using baculovirus-engineered mesenchymal stem cells. Biomaterials 2010, 31:3222-3230.
19. Lin C.-Y., Lu C.-H., Luo W.-Y., Chang Y.-H., Sung L.-Y., Chiu H.-Y., et al. Baculovirus as a gene delivery vector for cartilage and bone tissue engineering. Curr Gene Ther 2010, 10:242-254.
20. Sung L.-Y., Chen C.-L., Lin S.-Y., Hwang S.-M., Li K.-C., Lan A.S.-M., et al. Enhanced and prolonged baculovirus-mediated expression by incorporating recombinase system and in cis elements: a comparative study. Nucleic Acids Res 2013, [Epub ahead of print]. 10.1093/nar/gkt442.
21. Siltanen A., Kitabayashi K., Patila T., Ono M., Tikkanen I., Sawa Y., et al. Bcl-2 improves myoblast sheet therapy in rat chronic heart failure. Tissue Eng Part A 2011, 17:115-125.
22. Elloumi-Hannachi I., Yamato M., Okano T. Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine. JIntern Med 2010, 267:54-70.
23. Sung L.-Y., Lo W.-H., Chiu H.-Y., Chen H.-C., Chuang C.-K., Lee H.-P., et al. Modulation of chondrocyte phenotype via baculovirus-mediated growth factor expression. Biomaterials 2007, 28:3437-3447.
24. Lin C.-Y., Lin K.-J., Kao C.-Y., Chen M.-C., Yen T.-Z., Lo W.-H., et al. The role of adipose-derived stem cells engineered with the persistently expressing hybrid baculovirus in the healing of massive bone defects. Biomaterials 2011, 32:6505-6514.
25. Lo W.-H., Hwang S.-M., Chuang C.-K., Chen C.-Y., Hu Y.-C. Development of a hybrid baculoviral vector for sustained transgene expression. Mol Ther 2009, 17:658-666.
26. Hu Y.-C., Tsai C.-T., Chang Y.-J., Huang J.-H. Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Prog 2003, 19:373-379.
27. Gerber B.L., Raman S.V., Nayak K., Epstein F.H., Ferreira P., Axel L., et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. JCardiovasc Magn Reson 2008, 10:18.
28. Su M.Y., Yang K.C., Wu C.C., Wu Y.W., Yu H.Y., Tseng R.Y., et al. First-pass myocardial perfusion cardiovascular magnetic resonance at 3 Tesla. JCardiovasc Magn Reson 2007, 9:633-644.
29. Marsano A., Maidhof R., Luo J., Fujikara K., Konofagou E.E., Banfi A., et al. The effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarction. Biomaterials 2013, 34:393-401.
30. McGinn A.N., Nam H.Y., Ou M., Hu N., Straub C.M., Yockman J.W., et al. Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium. Biomaterials 2011, 32:942-949.
31. Wang L., Deng J., Tian W., Xiang B., Yang T., Li G., et al. Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. Am J Physiol-Heart Circ Physiol 2009, 297:H1020-H1031.
32. Lee W.Y., Wei H.J., Lin W.W., Yeh Y.C., Hwang S.M., Wang J.J., et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials 2011, 32:5558-5567.
33. Bel A., Planat-Bernard V., Saito A., Bonnevie L., Bellamy V., Sabbah L., et al. Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells. Circulation 2010, 122:S118-S123.
34. Matsuda N., Shimizu T., Yamato M., Okano T. Tissue engineering based on cell sheet technology. Adv Mater 2007, 19:3089-3099.
35. Siltanen A., Kitabayashi K., Lakkisto P., Makela J., Patila T., Ono M., et al. hHGF overexpression in myoblast sheets enhances their angiogenic potential in rat chronic heart failure. PLoS One 2011, 6:e19161.
36. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 2001, 104:I-207-I-212.
37. Kim S.H., Moon H.H., Kim H.A., Hwang K.C., Lee M., Choi D. Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther 2011, 19:741-750.
38. Cho Y.-H., Cha M.-J., Song B.-W., Kim I.-K., Song H., Chang W., et al. Enhancement of MSC adhesion and therapeutic efficiency in ischemic heart using lentivirus delivery with periostin. Biomaterials 2012, 33:1376-1385.
39. Alshammary S., Fukushima S., Miyagawa S., Matsuda T., Nishi H., Saito A., et al. Impact of cardiac stem cell sheet transplantation on myocardial infarction. Surg Today 2013, 1-7.
40. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?. Nat Med 2000, 6:1102-1103.
41. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000, 102:898-901.
42. Heckl D., Schwarzer A., Haemmerle R., Steinemann D., Rudolph C., Skawran B., et al. Lentiviral vector induced insertional haploinsufficiency of Ebf1 causes murine leukemia. Mol Ther 2012, 20:1187-1195.
43. Modlich U., Navarro S., Zychlinski D., Maetzig T., Knoess S., Brugman M.H., et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther 2009, 17:1919-1928.
44. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCcormack M.P., Wulffraat N., Leboulch P., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
45. Zhang D., Huang W., Dai B., Zhao T., Ashraf A., Millard R.W., et al. Genetically manipulated progenitor cell sheet with diprotin A improves myocardial function and repair of infarcted hearts. Am J Physiol-Heart Circ Physiol 2010, 299:H1339-H1347.
46. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286:2244-2245.
47. Chen C.-Y., Lin C.-Y., Chen G.-Y., Hu Y.-C. Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol Adv 2011, 29:618-631.
48. Chen C.-Y., Wu H.-H., Chen C.-P., Chern S.-R., Hwang S.-M., Huang S.-F., et al. Biosafety assessment of human mesenchymal stem cells engineered by hybrid baculovirus vectors. Mol Pharmaceut 2011, 8:1505-1514.
49. Lu C.-H., Yeh T.-S., Yeh C.-L., Fang Y.-H.D., Sung L.-Y., Lin S.-Y., et al. Regenerating cartilages by engineered ASCs: prolonged TGF-β3/BMP-6 expression improved articular cartilage formation and restored zonal structure. Mol Ther 2013, [Epub ahead of print]. 10.1038/mt.2013.165.